| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.0077 | 0.8 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | -0.009 | 0.8 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.0085 | 0.8 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | -0.0084 | 0.8 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | 0.0074 | 0.8 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.0077 | 0.8 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |